韩国化脓性汗腺炎的患病率及相关合并症:一项全国性人群研究
该研究利用韩国国民健康保险数据库2007至2016年数据,纳入28516例化脓性汗腺炎(HS)患者及年龄性别匹配的对照,估计韩国HS的时期患病率为0.06%(每10万人55.8例,95%CI 55.1-56.4),男女比例为1:1.6。HS患者类风湿关节炎、强直性脊柱炎、1型糖尿病、溃疡性结肠炎、2型糖尿病、高血压、高脂血症、聚合性痤疮、藏毛囊肿、银屑病、坏疽性脓皮病、斑秃和白癜风的风险显著增加。
要点
- 韩国HS患病率为0.06%(每10万人55.8例,95%CI 55.1-56.4),低于西方人群。
- HS患者中男性占61.3%,女性占38.7%,男女比例为1:1.6。
- HS患者类风湿关节炎、强直性脊柱炎、1型糖尿病、溃疡性结肠炎、2型糖尿病、高血压、高脂血症、聚合性痤疮、藏毛囊肿、银屑病、坏疽性脓皮病、斑秃和白癜风风险显著增加。
核心结论
- 韩国HS总体患病率低于西方人群,且以男性患者为主。
研究设计与样本
- 基于韩国国民健康保险(NHI)理赔数据库2007至2016年数据的全国性人群研究,纳入所有HS患者及年龄和性别匹配的无HS对照。
主要发现
- 共识别28516例HS患者,其中男性61.3%,女性38.7%。
- 时期患病率为0.06%,每10万人55.8例(95%CI 55.1-56.4),男女比例为1:1.6。
- HS患者类风湿关节炎、强直性脊柱炎、1型糖尿病、溃疡性结肠炎、2型糖尿病、高血压、高脂血症、聚合性痤疮、藏毛囊肿、银屑病、坏疽性脓皮病、斑秃和白癜风风险显著增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of hidradenitis suppurativa (HS) in Asia is unknown. The associations between HS and other autoimmune disorders have rarely been reported. OBJECTIVE: We sought to determine the prevalence of and diseases associated with HS using the National Health Insurance (NHI) database. METHODS: We examined Korean NHI claim database data from 2007 to 2016. We enrolled all patients with HS and age- and sex-matched control subjects without HS. We estimated the period prevalence of HS and associated comorbidities in Korea. RESULTS: We identified 28 516 patients with HS (61.3% males and 38.7% females). The period prevalence rate was 0.06%, 55.8 patients (95% confidence interval 55.1-56.4) per 100 000 persons, and the female-to-male ratio was 1 : 1.6. HS patients were at significantly increased risk of rheumatoid arthritis, ankylosing spondylitis, type 1 diabetes, ulcerative colitis, type 2 diabetes, hypertension, hyperlipidaemia, acne conglobata, pilonidal cysts, psoriasis, pyoderma gangrenosum, alopecia areata and vitiligo. CONCLUSION: The overall prevalence of HS in Korea was lower than that in Western populations, and male patients predominated.
引用
- Lee JH, Kwon HS, Jung HM, et al. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2018. PMID: 29761904. doi:10.1111/jdv.15071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。